Circulating atypical cells detected in blood of lung cancer patients Warsaw, October 2021 – New study data presented at the European Congress of Cytology – held from 3-6 Oct in Warsaw, Poland – confirmed that X-ZELL is able to detect tumour-associated circulating...
X-ZELL hMX™ technology now available for research use Singapore, September 2021 – X-ZELL’s widely recognised high-gradient magnetic Cell Separator (hMX™) is now available to researchers worldwide. Previously exclusive to X-ZELL, the patented system is part of the...
X-ZELL launches new Imaging Technology unit Singapore, August 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the formation of a new, interdisciplinary Imaging Technology division. The announcement comes on the back of a new collaboration agreement...
X-ZELL announces strategic expansion into Europe Lennestadt, February 2021 – Award-winning Singaporean start-up, X-ZELL, has announced the opening of a new international office in Germany. Recently voted the second-most innovative health-tech start-up in the world1,...
Episode 17 HOW X-ZELL MADE 2020 work – and why the best is yet to come For many of us, 2020 has been more disruptive, heartbreaking and disorienting than we could have imagined – both personally and professionally. Marred with loss and uncertainty, political...
